Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRAAP2: Tranexamic Acid for Preventing Postpartum Hemorrhage Following Cesarean Delivery
NCT03431805Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Mar 2018
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tranexamic acid in postpartum hemorrhage (PPH) (2 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Postpartum Hemorrhage at day 2. Started Mar 2018; status: completed.
02
Drugs
tranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT03431805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03431805.